Literature DB >> 9284825

Amplification of the c-erbB-2 (HER-2/neu) gene in gastric cancer cells. Detection by fluorescence in situ hybridization.

T Ishikawa1, M Kobayashi, M Mai, T Suzuki, A Ooi.   

Abstract

Amplification of the c-erbB-2 gene was examined in 120 gastric adenocarcinomas by dual-color fluorescence in situ hybridization (FISH) using probes for centromere 17 and the 17q11.2-12. The results were compared with Southern blot analysis and immunohistochemistry of c-erbB-2 overexpression. FISH was successful in 105 tumors, and the amplification was found in 19 tumors. FISH on 17 tumors revealed high-level amplification; in 15, the predominant cancer populations had amplified c-erbB-2 gene with the signals forming one or two clusters, indicating that the amplified gene was present in homogeneously staining regions. In two tumors, most cancer cells had multiple scattered c-erbB-2 signals, indicating that the amplicon was within double-minute chromosomes. The other two tumors had a few additional copies of the c-erbB-2 gene. Seventeen tumors had increased numbers of the gene probably due to polysomy 17, and sixty-nine tumors had no aberrations of chromosome 17. Immunohistochemically, distinct membrane staining was found only in the 17 tumors with the high-level amplification. It is concluded that, in gastric adenocarcinomas, high-level amplification produces the c-erbB-2 gene principally in homogeneously staining region form and occasionally in double-minute form and is thought to control the over-expression of the protein in the cytoplasmic membrane.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9284825      PMCID: PMC1857861     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  35 in total

Review 1.  The arrangement of interphase chromosomes: structural and functional aspects.

Authors:  A J Hilliker; R Appels
Journal:  Exp Cell Res       Date:  1989-12       Impact factor: 3.905

Review 2.  The importance of circular DNA in mammalian gene amplification.

Authors:  G M Wahl
Journal:  Cancer Res       Date:  1989-03-15       Impact factor: 12.701

3.  Localization of the human erbB-2 gene on normal and rearranged chromosomes 17 to bands q12-21.32.

Authors:  N C Popescu; C R King; M H Kraus
Journal:  Genomics       Date:  1989-04       Impact factor: 5.736

4.  Sporadic amplification of the HER2/neu protooncogene in adenocarcinomas of various tissues.

Authors:  M Tal; M Wetzler; Z Josefberg; A Deutch; M Gutman; D Assaf; R Kris; Y Shiloh; D Givol; J Schlessinger
Journal:  Cancer Res       Date:  1988-03-15       Impact factor: 12.701

5.  Expression of c-erbB-2 oncoprotein in gastric carcinoma. Immunoreactivity for c-erbB-2 protein is an independent indicator of poor short-term prognosis in patients with gastric carcinoma.

Authors:  Y Yonemura; I Ninomiya; S Ohoyama; H Kimura; A Yamaguchi; S Fushida; T Kosaka; K Miwa; I Miyazaki; Y Endou
Journal:  Cancer       Date:  1991-06-01       Impact factor: 6.860

6.  Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer.

Authors:  D J Slamon; W Godolphin; L A Jones; J A Holt; S G Wong; D E Keith; W J Levin; S G Stuart; J Udove; A Ullrich
Journal:  Science       Date:  1989-05-12       Impact factor: 47.728

7.  In situ hybridization as a tool to study numerical chromosome aberrations in solid bladder tumors.

Authors:  A H Hopman; F C Ramaekers; A K Raap; J L Beck; P Devilee; M van der Ploeg; G P Vooijs
Journal:  Histochemistry       Date:  1988

8.  Genetic alterations of the c-erbB-2 oncogene occur frequently in tubular adenocarcinoma of the stomach and are often accompanied by amplification of the v-erbA homologue.

Authors:  J Yokota; T Yamamoto; N Miyajima; K Toyoshima; N Nomura; H Sakamoto; T Yoshida; M Terada; T Sugimura
Journal:  Oncogene       Date:  1988-03       Impact factor: 9.867

9.  Correlation of c-erbB-2 gene amplification and protein expression in human breast carcinoma with nodal status and nuclear grading.

Authors:  M S Berger; G W Locher; S Saurer; W J Gullick; M D Waterfield; B Groner; N E Hynes
Journal:  Cancer Res       Date:  1988-03-01       Impact factor: 12.701

10.  Alterations of oncogenes in metastatic tumours of human gastric carcinomas.

Authors:  T Tsujino; K Yoshida; H Nakayama; H Ito; T Shimosato; E Tahara
Journal:  Br J Cancer       Date:  1990-08       Impact factor: 7.640

View more
  20 in total

1.  HER-2/neu overexpression is an independent prognostic factor in colorectal cancer.

Authors:  Dong Il Park; Mun Su Kang; Suk Joong Oh; Hong Joo Kim; Yong Kyun Cho; Chong Il Sohn; Woo Kyu Jeon; Byung Ik Kim; Won Kon Han; Hungdai Kim; Seung Ho Ryu; Antonia R Sepulveda
Journal:  Int J Colorectal Dis       Date:  2006-09-01       Impact factor: 2.571

2.  Comparison of adjuvant activity of N- and C-terminal domain of gp96 in a Her2-positive breast cancer model.

Authors:  Nafiseh Pakravan; Zuhair Mohammad Hassan
Journal:  Cell Stress Chaperones       Date:  2011-02-26       Impact factor: 3.667

3.  HER2 amplification in gastroesophageal adenocarcinoma: correlation of two antibodies using gastric cancer scoring criteria, H score, and digital image analysis with fluorescence in situ hybridization.

Authors:  Oana M Radu; Tyler Foxwell; Kathleen Cieply; Sarah Navina; Sanja Dacic; Katie S Nason; Jon M Davison
Journal:  Am J Clin Pathol       Date:  2012-04       Impact factor: 2.493

4.  Co-administration of GP96 and Her2/neu DNA vaccine in a Her2 breast cancer model.

Authors:  Nafiseh Pakravan; Ladan Langroudi; Monire Hajimoradi; Zuhair Mohammad Hassan
Journal:  Cell Stress Chaperones       Date:  2010-06-12       Impact factor: 3.667

5.  Adjuvant activity of GP96 C-terminal domain towards Her2/neu DNA vaccine is fusion direction-dependent.

Authors:  Nafiseh Pakravan; Seyed Mahmoud Hashemi; Zuhair Mohammad Hassan
Journal:  Cell Stress Chaperones       Date:  2010-08-22       Impact factor: 3.667

6.  Imbalances of chromosome 17 in medulloblastomas determined by comparative genomic hybridisation and fluorescence in situ hybridisation.

Authors:  J Nicholson; C Wickramasinghe; F Ross; J Crolla; D Ellison
Journal:  Mol Pathol       Date:  2000-12

7.  Prognostic implications of EGFR and HER-2 alteration assessed by immunohistochemistry and silver in situ hybridization in gastric cancer patients following curative resection.

Authors:  Ho Suk Oh; Dae-Woon Eom; Gil Hyun Kang; Yong Chel Ahn; Sang Jin Lee; Ji-Hoon Kim; Hyuk Jai Jang; Eun Jung Kim; Kwang Hoon Oh; Heui June Ahn
Journal:  Gastric Cancer       Date:  2013-08-17       Impact factor: 7.370

Review 8.  Role of human epidermal growth factor receptor 2 in gastric cancer: biological and pharmacological aspects.

Authors:  Jan Trøst Jørgensen
Journal:  World J Gastroenterol       Date:  2014-04-28       Impact factor: 5.742

9.  Human epidermal growth factor receptor 2 (HER-2) status evaluation in advanced gastric cancer using immunohistochemistry versus silver in situ hybridization.

Authors:  Nuray Kepil; Sebnem Batur; Ceyda Sonmez Wetherilt; Sibel Erdamar Cetin
Journal:  Bosn J Basic Med Sci       Date:  2017-05-20       Impact factor: 3.363

10.  TOPOIIalpha and HER-2/neu overexpression/amplification in Barrett's oesophagus, dysplasia and adenocarcinoma.

Authors:  Elisa Rossi; Vincenzo Villanacci; Gabrio Bassotti; Francesco Donato; Andrea Festa; Gianpaolo Cengia; Salvatore Grisanti; Renzo Cestari
Journal:  Histopathology       Date:  2010-06-16       Impact factor: 5.087

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.